Reduced Tumor Size of Untreated Papillary Thyroid Carcinoma After Immune Checkpoint Inhibitor-Induced Thyroiditis

By sjmartinez • September 22, 2023

Chen DH, Lenz HJ, Lechner MG, Angell TE. Reduced Tumor Size of Untreated Papillary Thyroid Carcinoma After Immune Checkpoint Inhibitor-Induced Thyroiditis. AACE Clin Case Rep. 2023 Jun 3;9(5):162-165. doi: 10.1016/j.aace.2023.05.009. PMID: 37736314; PMCID: PMC10509378.

Tags: efficacy, Endocrinology, immune checkpoint inhibitors, immune-related adverse events, papillary thyroid carcinoma, Publications, thyroiditis

Influence of Thyroglobulin Autoantibodies on Thyroglobulin Levels Measured by Different Methodologies: IMA, LC-MS/MS, and RIA

Petrovic I, LoPresti J, Fatemi S, Gianoukakis A, Burman K, Gomez-Lima CJ, Nguyen CT, Spencer CA. Influence of Thyroglobulin Autoantibodies on Thyroglobulin Levels Measured by[...]

Outcomes of Cytologically Indeterminate Thyroid Nodules Managed With Genomic Sequencing Classifier

Ahmadi S, Kotwal A, Bikas A, Xiang P, Goldner W, Patel A, Hughes EG, Longstaff X, Yeh MW, Livhits MJ. Outcomes of Cytologically Indeterminate Thyroid[...]

Phosphate Binder Impairs Levothyroxine Absorption in a Hypothyroid Patient With End-Stage Renal Disease

Ko M, Barai R, Brent G. Phosphate Binder Impairs Levothyroxine Absorption in a Hypothyroid Patient With End-Stage Renal Disease. Cureus. 2024 Oct 15;16(10):e71551. doi: 10.7759/cureus.71551.[...]